Panel: EU Accord Threatens India; World Customs Body Scales Back IP Enforcement11/06/2009 by David Cronin for Intellectual Property Watch Leave a CommentBRUSSELS – India’s status as a top world supplier of generic medicines could be threatened by a free trade agreement its government is negotiating with the European Union, a new study has concluded. Separately, the World Customs Organization has abandoned its intellectual property rights enforcement group, replacing it with a non-policymaking information committee.
L’UE débat du droit d’auteur, de l’accès aux œuvres et des artistes dans le contexte de l’ère numérique29/04/2009 by David Cronin for Intellectual Property Watch 1 CommentBRUXELLES – « Le droit d’auteur devrait être aboli car il nuit à la diversité culturelle », a-t-on entendu lors d’une conférence à Bruxelles.
EU Stakeholders Debate Copyright, Access And Artists In Digital Age24/04/2009 by David Cronin for Intellectual Property Watch 4 CommentsBRUSSELS – Copyright should be abolished because it undermines cultural diversity, a Brussels conference has been told.
欧盟有关知识产权的强硬规定被视为对贫困国家医药获得的威胁24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment布鲁塞尔 – 全球公共卫生活跃分子声称，欧盟执意要在一系列自由贸易协议中添加有关医药专利的强硬规定将会妨害发展中国家获得医药。
لأحكام التجارية القوية للاتحاد الأوروبي حول الملكية الفكرية تعتبر تهديدا على نفاذ البلدان الفقيرة إلى الأدوية24/02/2009 by David Cronin for Intellectual Property Watch Leave a Commentابروكسل- إن الجهود التي يبذلها الاتحاد الأوروبي لإدراج أحكام حول براءات المستحضرات الصيدلانية في سلسلة من اتفاقات التجارة الحرة التي يتفاوض حولها قد تشكل تهديدا على إمكانية الحصول على الأدوية في البلدان النامية، على حد قول الناشطين في مجال الصحة العامة على الصعيد العالمي.
Des dispositions renforçant la propriété intellectuelle dans certains accords de l’UE menacent l’accès aux médicaments dans les pays pauvres24/02/2009 by David Cronin for Intellectual Property Watch Leave a CommentBRUXELLES – Selon certains activistes de la santé publique mondiale, les efforts de l’Union européenne (UE) pour intégrer des dispositions sur les brevets pharmaceutiques dans un certain nombre d’accords de libre échange en cours de négociation pourraient mettre en péril l’accès aux médicaments dans les pays en développement.
Las estrictas disposiciones comerciales de la UE sobre PI representan una amenaza para el acceso de los países pobres a los medicamentos24/02/2009 by David Cronin for Intellectual Property Watch 1 CommentBRUSELAS- Los esfuerzos de la Unión Europea para introducir disposiciones firmes en materia de patentes farmacéuticas en una serie de acuerdos de libre comercio que está negociando podrían poner en peligro el acceso a los medicamentos en los países en desarrollo, según han afirmado activistas de la salud pública a nivel mundial.
Strong EU Trade Provisions On IP Seen As Threat To Poor Nations’ Medicines Access18/02/2009 by David Cronin for Intellectual Property Watch 2 CommentsBRUSSELS – Efforts by the European Union to insert strong provisions on pharmaceutical patents in a series of free trade agreements it is negotiating could imperil access to medicines in developing countries, global public health activists have alleged.As part of trade talks being conducted with India, Colombia, Peru and a regional grouping in south-east Asia, EU officials have proposed that drug-makers should benefit from a robust intellectual property regime. National regulatory authorities in the countries concerned would be prevented for lengthy periods from using data provided by a company that holds a drug patent in order to authorise a generic version of that medicine.
Proposed EU Copyright Term Extension Faces Vocal Opposition In Parliament27/01/2009 by David Cronin for Intellectual Property Watch 8 CommentsBy David Cronin for Intellectual Property Watch BRUSSELS – Strong opposition is being voiced by members of the European Parliament over plans to extend the copyright protection applying to sound recordings from 50 to 95 years. Both left and right-leaning Parliament members (MEPs) have signalled that they intend to vote against the proposed extension at […]
Debate Over EU Finding That Pharmaceutical Firms Abusing Patent System05/12/2008 by David Cronin for Intellectual Property Watch 2 CommentsBy David Cronin for Intellectual Property Watch BRUSSELS – Leading pharmaceutical companies are using the patent system to delay the entry of generic medicines onto the market, the European Commission has alleged, sparking a debate at a conference held here this week. In spring 2009, the EU’s executive branch will present the findings of an […]
